ZTS

Zoetis Inc.

NYSEHealth CarePharmaceuticals

Live price

$81.72

+2.90 (+3.68%)

O $79.30 · H $82.32 · L $79.30

Compare

Market cap

$33.3B

P/E (TTM)

12.60

EPS (TTM)

$6.04

Dividend yield

2.67%

52w high

$171.52

52w low

$72.38

Beta

0.72

ROE (TTM)

62.4%

Price action

ZTS chart

Powered by TradingView

Chart loads on scroll…

About

Zoetis Inc

Exchange

NEW YORK STOCK EXCHANGE, INC.

Country

US

Industry

Pharmaceuticals

IPO

2013-02-01

Visit company site↗

Latest on ZTS

Yahoo · 6/11/2026
Is PAHC Undervalued at 10x Earnings vs Peers?
Phibro trades near 10x forward earnings vs higher peer multiples as strong Q3 beat, margin gains and 2026 guidance support a modest upside case.
ChartMill · 6/11/2026
Zoetis Inc (NYSE:ZTS) Offers a Winning Combination of Dividend Growth and Strong Fundamentals
Discover Zoetis (ZTS), a Best Dividend screen pick with a 1.64% yield, 20.56% dividend growth, strong profitability (9/10), and a low 33.64% payout ratio for sustainable income.

SeekingAlpha · 6/11/2026

Zoetis Might Be Cheap For A Reason

Zoetis (ZTS) is down ~70% and trades at low multiples. Weak U.S. Companion Animal segment prompted a downwardly revised 2026 outlook. See more here.

Yahoo · 6/10/2026

Chewy Earnings Are Unremarkable. The Stock Is Sharply Higher Anyway.

Shares of the pet supplies retailer rise after Chewy posts first-quarter adjusted earnings that meet expectations.

Yahoo · 6/9/2026

Here’s What Analysts Are Saying About Zoetis Inc. (ZTS)

Zoetis Inc. (NYSE:ZTS) is one of the best healthcare stocks to buy with highest upside potential. Zoetis Inc. (NYSE:ZTS) received a rating update from Stifel on May 22. The firm cut the price target on the stock to $95 from $105 while maintaining a Hold rating on the shares, and told investors that the company’s revised […]

Important

Not financial advice

Information about ZTS is provided for educational purposes only. Stock trading carries risk of loss. Full disclaimer.